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Abstract
Background: The integrin CD11c is known as a marker for dendritic cells and has recently been
described on T cells following lymphotropic choriomeningitis virus infection, a systemic infection
affecting a multitude of organs. Here, we characterise CD11c bearing T cells in a murine model of
localised pulmonary infection with respiratory syncytial virus (RSV).
Methods: Mice were infected intranasally with RSV and expression of β2 integrins and T
lymphocyte activation markers were monitored by flow cytometry. On day 8 post RSV infection
CD11c+ CD8+ and CD11c- CD8+ T cells were assessed for cytokine production, cytotoxic activity
and migration. Expression of CD11c mRNA in CD8+ T cells was assessed by quantitative PCR.
Results: Following RSV infection CD11c+ CD8+ T cells were detectable in the lung from day 4
onwards and accounted for 45.9 ± 4.8% of CD8+ T cells on day 8 post infection, while only few
such cells were present in mediastinal lymph nodes, spleen and blood. While CD11c was virtually
absent from CD8+ T cells in the absence of RSV infection, its mRNA was expressed in CD8+ T cells
of both naïve and RSV infected mice. CD11c+, but not CD11c-, CD8+ T cells showed signs of recent
activation, including up-regulation of CD11a and expression of CD11b and CD69 and were
recruited preferentially to the lung. In addition, CD11c+ CD8+ T cells were the major subset
responsible for IFNγ production, induction of target cell apoptosis in vitro and reduction of viral
titres in vivo.
Conclusion: CD11c is a useful marker for detection and isolation of pulmonary antiviral cytotoxic
T cells following RSV infection. It identifies a subset of activated, virus-specific, cytotoxic T cells that
exhibit potent antiviral effects in vivo.
Background
Beta2 integrins, which are restricted to leukocytes, consist
of a common β-chain (CD18) and the distinct α-chains
CD11a (LFA-1), CD11b (Mac-1/ CR3) or CD11c
(p150,95/ CR4) [1]. While CD11a is expressed widely on
leukocytes, expression of CD11b and CD11c was thought
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to be confined to cells of myeloid origin and these mole-
cules have been used as markers to define certain cell pop-
ulations, e.g. CD11b for macrophages [2] and CD11c for
dendritic cells [3]. β2 integrins are of critical importance
for the development of functional immune responses; a
mutation in the CD18 gene, resulting in decreased expres-
sion of β2 integrins and in defective migration of granulo-
cytes, causes an immune defect termed leukocyte-
adhesion deficiency [1]. CD11a/LFA-1 has been shown to
be involved in T cell activation [4], T cell recruitment [5]
and target cell killing [6] by binding to its ligand intercel-
lular adhesion molecule-1 (CD54) thus mediating adhe-
sive cell-cell-interactions. Over the past ten years several
groups have reported that CD11b is expressed on acti-
vated cytotoxic T cells [7,8] and that it is also involved in
T cell migration into inflamed tissues [9]. CD11c expres-
sion on T cells has been detected initially on a population
of intestinal intraepithelial lymphocytes [10] and more
recently on CD8+ T cells following systemic viral infec-
tions [11]. The studies regarding β2 integrins on T cells
were mostly conducted in mouse-models of infection
with LCMV, a virus that induces systemic immune
responses involving many different organs [12]. Here, we
studied CD11c+ T cells during a localised infection of the
lung with RSV, monitoring their distribution and compar-
ing the pulmonary to the systemic immune response. We
hypothesized that CD11c is a marker of antigen-specific
cytotoxic T cells, which is expressed following activation,
rather than being transferred from APC during cell-cell
interactions. Such a transfer from APC to T cells has been
described for the co-stimulatory molecule CD80 [13]. In
addition, we sought to define a function of CD11c when
expressed on T cells following RSV infection.
Materials and methods
Virus and animals
Human RSV, type A2 from ATCC (Rockville, MD) free of
mycoplasma contamination was used. The virus was cul-
tured on HEp-2 cells from ATCC in Dulbecco's modified
Eagle Medium (Invitrogen, Paisley, UK) containing 5%
heat inactivated fetal calf serum and 1 % Penicillin / Strep-
tomycin both from Sigma (Gillingham, UK).
Female BALB/c AnNCrl mice, 8 to 12 weeks of age, free of
specific pathogens, were obtained from Charles River Lab-
oratories (Margate, UK) and kept under specific pathogen
free conditions. All experimental animals used in this
study were under a protocol approved by the Home
Office, London, UK. Mice were infected under light
anesthesia with isoflurane by intranasal inoculation of
RSV (5 × 105 PFU in 70 µl). Controls were untreated or
mock infected with RSV, inactivated by irradiation with
UV-light. RSV infection was confirmed by plaque assay as
described previously [14]. Infection could be demon-
strated in all infected animals tested but not in controls.
Experimental Protocols
Mice were infected with RSV. On days 0 (naive controls),
4, 6, 8, 10, and 21 post infection mice were sacrificed and
lungs, spleens, mediastinal lymph nodes (MLN) and
blood cells were harvested. For secondary RSV infection
mice were infected 28 days after primary infection. Aller-
gic airway inflammation was induced by intraperitoneal
injection of OVA in Alum on days 0 and 14. On days 21
to 23 mice were challenged intranasally with 75 µl 1%
OVA in PBS. Mice were sacrificed 24 hours after the last
OVA challenge. Organs were disrupted using a steel mesh,
and red blood cells were lysed with ACK lysis buffer. For
isolation of CD8+ cells lungs were minced, incubated in
collagenase (Sigma) solution and mononuclear cells were
prepared using a Ficoll (Biochrom) gradient (density =
1.09 g/l). Cell numbers were assessed by counting in a
Neubauer chamber.
Flow cytometry
Fc-receptors were blocked with anti-CD16/32-mAb
(2.4G2), cells were incubated with appropriate antibodies
for 20 min at 4°C, washed, and suspended in staining
buffer. A FACScalibur flow cytometry cell analyzer (Bec-
ton Dickinson, Oxford, UK) was used for data acquisition
and WinMDI software (Scripps institute, La Jolla, USA) for
analysis. The following antibodies (Becton Dickinson)
were used: anti-CD11c (HL3), anti-CD3 (145-2C11),
anti-CD69 (H1.2F3), anti-CD54 (3E2), and anti-F4/80
(Serotec, Oxford, UK) were FITC-conjugated; anti-CD3
(145-2C11), anti-CD4 (RM4-5), anti-CD8  (53-6.7),
anti-CD11b (M1/70), anti-CD11c (HL3), anti-CD40 (3/
23), anti-CD62L (MEL-14), and anti-CD80 (16-10A1)
were PE-conjugated; anti-CD8α (53-6.7) was CyChrome-
conjugated; biotinylated anti-CD11c (N418, Serotec),
anti-CD11a (M17/4), and anti-CD11c (HL3) were stained
with streptavidin-CyChrome (Becton Dickinson). Rat
IgG2a (R35-95), rat IgG2b (R35-38), mouse IgG2b (49.2)
and hamster IgG (G235-2356) were used as isotype con-
trols. RSV-M2-pentamers (ProImmune, Oxford, UK) were
used according to manufacturer's instructions.
For intracellular cytokine staining, lung cell suspensions
were cultured at a concentration of 106/ml medium in 24
well plates for 4 h in the presence of PMA (50 ng/ml), ion-
omycin (500 ng/ml) (both Sigma, Gillingham, UK) and
Golgi Plug (1 µl/ml) (Becton Dickinson). Following fixa-
tion and permeabilization cells were stained with anti-IFN
γ (XMG1.2) or isotype control.
Isolation of CD8+ cells
Mononuclear cells from lungs were pooled and incubated
with anti-CD8-coated magnetic beads from Miltenyi (Ber-
gisch-Gladbach, Germany) according to manufacturer's
instructions. Cells were sorted by Auto-MACS (Miltenyi).
Purity of CD8+ cells assessed by FACS was at least 90%.
α
.
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For sorting of CD8+ cells into CD11c+ and CD11c- popula-
tions, cells were labeled with anti-CD11c-Fitc and anti
CD8-PE-antibodies and sorted on a FACSDiva (Becton
Dickinson).
In vitro Cytotoxicity assay
The assay was performed as described [15]. Briefly, P815
cells (ATCC) were used as target cells and labeled with 2
µM RSV-M2-peptide (ABC Synthesis, London, UK),
washed extensively and cultured in 96-well U-bottom
plates (104 cells/well in 100 µl). Sorted populations of
CD8+CD11c+ or CD8+CD11c- were labeled with CFSE (1
µM, Invitrogen, UK) and added to the target cells in the
concentrations indicated, resulting in a final volume of
200 µl/well. In some experiments effector cells were pre-
incubated with 5 µg/ml anti-CD11c-mAb (HL3; BD) or
isotype control-mAb (20 minutes, 4°C) prior to co-cul-
ture with target cells. Cells were incubated for 4 hr (37°C,
95% CO2), washed, and incubated with PBS/BSA/0.1%
sodium-azide containing 7-Aminoactinomycin D (7-
AAD) (20 µg/ml, Sigma, UK). Afterwards cells were
washed and fixed in 1% PFA containing Actinomycin D
(10 µg/ml, Sigma, UK) and analyzed directly on a FACS-
calibur (BD). Staining of CFSE-negative cells for 7-AAD
was analyzed and specific lysis calculated with the
formula:
%specific lysis = 100 × (% 7-AAD+ sample - % 7-AAD+
basal)/(100 - %7-AAD+ basal).
In vivo Cytotoxicity assay
CD11c+CD8+ or CD11c-CD8+ cells isolated by FACSDiva
(Becton Dickinson) from lungs harvested on dpi 8, were
adoptively transferred (2.5 × 105 cells per recipient) by
intra-tracheal application 1 hour after RSV infection of
recipient mice. On dpi 4 RSV titers in the lungs were deter-
mined by plaque assay as described [14].
Migration assay
Lungs of RSV infected mice were harvested on dpi 8, CD8+
cells were isolated and labeled with 1 µM CFSE. Cells were
incubated with 20 µg/ml of anti-CD11c antibodies (HL3,
BD or N418, Serotec) or isotype controls for 30 minutes
at 4°C and washed afterwards. Subsequently, cells were
adoptively transferred by intravenous injection into recip-
ient mice, which were either naïve or RSV infected (dpi4).
After 3 or 24 hours lungs, perfused with PBS via the right
ventricle, and spleens were harvested, cell suspensions
were generated and analyzed by FACS.
Real-time PCR
RNA was isolated from purified cells using RNeasy kit
(Qiagen, Hilden, Germany) according to the manufac-
turer's instructions, including a step for on column DNA
digestion. The isolated RNA was transcribed into cDNA
using Omniscript kit (Qiagen). Primers and probes for
CD11c (Applied Biosystems, Warrington, UK) and
murine GAPDH (Qiagen) were used according to manu-
facturers' instructions. Samples were done as duplicates
and analyzed on an ABI Prism 7000 light cycler PCR
machine (Applied Biosystems).
Statistical analysis
Data are expressed as mean ± standard deviation unless
indicated otherwise. Groups were compared by students t-
test. P values for significance were set at < 0.05.
Results
RSV infection results in increases in numbers of CD11c+ 
CD8+ T cells in the lung
Recently, we have reported a population of CD8+CD11c+
T cells in the lung ten days after RSV infection [14]. To
study the kinetics of these cells during infection, BALB/c
mice were infected with RSV, lungs were harvested at sev-
eral time points after infection and CD3-positive lym-
phocytes were monitored for expression of CD11c by
FACS. In naïve (Figure 1a, c) as well as mock-infected mice
(data not shown) only as little as 0.7 ± 0.3% of pulmonary
CD8+ T cells expressed CD11c. Following RSV infection,
numbers of CD11c+ CD8+ T cells increased significantly
until dpi 8 when 45.9 ± 4.8% of CD8+ T cells expressed
CD11c and declined thereafter. Interestingly, expression
of CD11c was hardly increased on CD3+ CD8- cells (Figure
1a), consisting mostly of CD4+ T cells (data not shown).
To analyze if CD11c is also expressed on T cells in other
organs than the lung during RSV infection, CD8+ T cells
were monitored in MLN, spleen and blood. In all of these
organs small increases in CD11c+ CD8+ T cells were
detected from dpi 4 onwards but their percentage
returned to baseline rapidly. Only in MLN, numbers of
CD8+ T cells expressing CD11c remained significantly ele-
vated on dpi 10 (Figure 1c). However, numbers of CD8+
CD11c+ cells in the lungs were 8 – 12-fold higher than in
any other organ at any time point assessed after RSV infec-
tion. Next, we asked if expression of CD11c on CD8+ T
cells is unique to primary infection. Analysis of T cells
from mice which were re-infected with RSV on dpi 28
showed that 31.9 ± 1.4% of pulmonary CD8+ T cells were
positive for CD11c already 4 days after secondary infec-
tion. Again CD11c expression was much lower in MLN,
spleen or blood and was not increased on CD3+CD8- cells
(data not shown). Since both primary and secondary RSV
infection resulted in appearance of CD8+ CD11c+ T cells
we asked if CD11c expression on T cells is a general phe-
nomenon in lung inflammation irrespective of etiology.
To this end, allergic airway inflammation was induced in
mice using a protocol, which leads to airway eosinophilia,
as well as antigen-specific Th2 cytokine production by
CD4+ lung cells (data not shown). In this setting, only 3.8
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Expression of CD11c on pulmonary CD8+ T cells following RSV infectionFigure 1
Expression of CD11c on pulmonary CD8+ T cells following RSV infection. Following primary RSV infection lungs, 
spleens, MLN and blood were harvested from BALB/c mice at the time points indicated. Cells were stained with antibodies to 
CD3, CD8, and CD11c, CD11b or F4/80. Dot plots show expression of CD11c and CD8 on cells gated for CD3+ lymphocytes 
harvested from A) lungs, B) spleen, MLN and blood. Numbers indicate the percentage of CD8+ cells. Quadrant settings were 
adjusted that less than 1% of CD8+ cells stained positive for the isotype control of anti-CD11c-mAb. C) Changes in expression 
of CD11c, CD11b and F4/80 on CD3+ CD8+ cells from lungs, spleen, MLN, and blood following RSV infection. Cells were 
stained with antibodies as indicated and analyzed by FACS. The percentage of CD3+8+ cells staining positive for CD11c (black 
squares), CD11b (open circles) or F4/80 (triangles) after subtraction of isotype controls is shown as mean ± SEM (n = 6, *p < 
0.05, significant difference versus dpi 0).
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± 1.0% of CD8+ T cells expressed CD11c and no changes
were observed in the CD3+ CD8- population. To examine
if other markers, expressed predominantly on cells of the
myeloid lineage, are also increased on T cells during RSV
infection we analyzed expression of CD11b and F4/80 on
T cells from lungs, MLN, spleen and blood. Kinetics of
CD11b expression on T cells paralleled CD11c expression,
with lower percentages of CD11b+ CD8+ T cells in the
lungs on dpi 8 and 10 (Figure 1c). Expression of the mac-
rophage marker F4/80 was only detectable in significant
amounts on splenic T cells on dpi 8 (Figure 1c).
Activation markers are expressed differentially on CD11c+ 
CD8+ and CD11c- CD8+ T cells
Having observed striking increases of CD8+ T cells express-
ing CD11c in the lung following RSV infection we asked if
these cells are phenotypically different regarding their
activation status compared to CD11c- CD8+ T cells. We
analyzed pulmonary CD8+ cells almost all of which are T
cells (>99% CD3+ in both naïve and infected mice) for
surface markers known to be regulated during activation.
CD69 was expressed on the majority of CD11c+ T cells but
only on a small proportion of CD11c- T cells (Figure 2a).
CD54, was up regulated on CD11c+ T cells, while expres-
sion on CD11c- T cells was comparable to pulmonary
CD8+ T cells from naïve mice (Figure 2b). CD62L is
expressed at high levels on naïve and memory T cells and
down-regulated on effector T cells. On most CD11c+ T
cells CD62L was detectable at low levels, while around
two thirds of the CD8+ CD11c- population was CD62Lhi.
Further, while only a small proportion of CD8+ T cells in
MLN expressed CD11c, expression profiles of CD69
(CD11c+ 45.5 ± 2.3% versus CD11c- 7.7 ± 3.7%) and
CD62Lhigh (CD11c+ 30.3 ± 8.5% versus CD11c- 87.1 ±
0.6%) on CD8+ T cells (97% of CD11c+ and 99% of
CD11c- cells were CD3+) indicated that these cells already
begin to express CD11c following activation in the drain-
ing lymph nodes.
Since most activated CD8+ T cells expressed CD11c, a sur-
face molecule of myeloid cells including APC, we
explored the expression of molecules involved in APC T
cell-interaction on pulmonary CD8+ T cells 8 days after
RSV infection. While CD40 was detectable neither on
CD11c+ nor on CD11c- CD8+ T cells, expression of CD80
was confined mostly to CD11c+ T cells (Figure 2a). In
addition, we measured co-expression of the β2 integrins
CD11c and CD11a or CD11b on CD8+ T cells following
RSV infection. Compared to CD11c- CD8+ T cells, CD11a
was up regulated on CD11c+ CD8+ cells and CD11b was
co-expressed on a subpopulation of CD11c+ cells (Figure
2a).
CD11c mRNA is expressed by both activated and resting 
CD8+ T cells
Surface molecules such as CD80 can be transferred from
APC to T cells by cell-cell contact [13]. Since both CD11c
and CD80 are expressed widely on murine APC we asked
whether the presence of CD11c on CD8+ T cells is due to
expression by T cells rather than to membrane transfer
from APC during T cell priming. CD8+ cells were purified
from lungs and spleens of RSV-infected or naïve mice,
RNA was isolated and the expression of CD11c analyzed
by quantitative PCR. CD11c+ pulmonary cells served as a
positive control while LA-4 cells, a pulmonary epithelial
cell line, and P815 cells, a mastocytoma cell line, were
used as negative controls. In two separate experiments,
expression levels of CD11c normalized to GAPDH were
nearly equal in CD11c+ (relative expression = 1.05 ± 0.06,
n = 4) and CD8+ (relative expression = 1.08 ± 0.03) cells
from the lung following RSV infection. Surprisingly,
CD11c mRNA could also be detected in comparable
amounts in CD8+ cells isolated from spleens of naïve mice
(relative expression = 1.12 ± 0.08). CD11c mRNA was nei-
ther detectable in P815 cells nor in LA-4 cells. These find-
ings suggest that CD11c mRNA is constitutively expressed
in CD8+ T cells.
CD11c+ CD8+ cells are IFNγ producing, virus-specific, 
potent cytotoxic T cells
To characterize the function of CD11c+ T cells in RSV
infection we determined their capacity to produce IFNγ.
Pulmonary cell suspensions, harvested 8 days after RSV
infection, were incubated with medium or PMA/ionomy-
cin and CD8+ T cells were analyzed for intracellular IFNγ
production. In un-stimulated cells IFNγ was detectable in
less than 3% of CD11c+ or CD11c- CD8+ cells while fol-
lowing stimulation the percentage of IFNγ-producing
CD11c+ CD8+ cells was significantly higher than in
CD11c- cells (38.4 ± 5.0% versus 25.5 ± 3.0%, respec-
tively, n = 4, p < 0.05). The crucial function of CTL in viral
infections is to induce apoptosis and lysis of infected cells
to eliminate replicating virus. To determine if CD11c+ T
cells are more effective CTL during RSV infection than
their CD11c- counterparts we initially analyzed induction
of apoptosis in RSV M2 peptide-labeled P815 cells. CD8+
lung cells were isolated by MACS and enriched for
CD11c+ by FACS sorting, resulting in about 80% of
CD11c+ CTL in the positive population, while the negative
fraction still contained about 25% of CD11c+ CD8+ T
cells. These CD11c+ and CD11c- CD8+ T cell populations
were used as effector cells in a cytotoxicity assay. Loss of
membrane integrity in apoptotic CFSE- target cells enables
detection of dying cells by staining of DNA with the fluo-
rescent dye 7-AAD (Figure 3a). CD11c+ T cells were signif-
icantly more efficient in inducing apoptosis in target cells
than CD11c- T cells (Figure 3b). Pre-incubation of effector
cells with anti-CD11c-mAb had no effect on the cytotoxic
Respiratory Research 2005, 6:70 http://respiratory-research.com/content/6/1/70
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activity of either CD11c+ (Figure 3b) or CD11c- cells (data
not shown). To assess the frequency of RSV-specific CTL
directly we stained lung cells with RSV M2-pentamers,
which recognize cells specific for this dominant CTL
epitope. About 38% of CD11c+ CTL were M2-Pentamer+
and at 81% the majority of T cells expressing the RSV-M2
specific TCR was found to be CD11c+ (Figure 3c). In con-
trast, only about 10% of CD11c- CD8+ T cells were specific
for RSV M2-peptide. These results show that CD11c+
CD8+ T cells, which include the majority of RSV specific
CTL, are highly effective in inducing target cell apoptosis
in vitro. To compare antiviral efficiency of CD11c+ and
CD11c- CD8+ T cells in vivo, these cells were isolated by
FACS sorting from lungs on dpi 8 and adoptively trans-
ferred one hour after RSV infection of recipient mice.
Transfer of low numbers (2.5 × 105) of CD11c+ CTL
(purity > 83%) significantly reduced lung RSV titers on
dpi 4 (Figure 3d). Transfer of the same numbers of CD11c-
Differential expression of surface markers on pulmonary CD11c+ and CD11c- CD8+ T cellsFigu  2
Differential expression of surface markers on pulmonary CD11c+ and CD11c- CD8+ T cells. Lungs of naive mice or 
on day 8 after RSV infection were harvested. Cells were stained with antibodies for CD8, CD11c, and the surface markers 
indicated. A) Dot plots show expression of CD11c versus the indicated marker on cells gated for lymphocyte size and CD8 
expression after RSV infection. Numbers indicate the percentage of cells in corresponding quadrants. Quadrants were set 
according to isotype controls except for CD11a, CD54 and CD62L. Since these three molecules are expressed to a consider-
able degree on naïve CD8 T cells, this expression was used for quadrant settings to highlight differences in CD11+ CTL. B) His-
tograms show expression of CD54, CD62L, and CD69 on pulmonary CD8+ cells from naïve (dotted line) or RSV infected mice 
(CD11c+ cells: black line, CD11c- cells: filled histogram).
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Target cell lysis, binding of RSV M2-pentamer and reduction in viral titers by CD8+ T cells following RSV infectionFigure 3
Target cell lysis, binding of RSV M2-pentamer and reduction in viral titers by CD8+ T cells following RSV infec-
tion. Lungs were harvested on day 8 after RSV infection and CD8+11c+ or CD8+11c- cells were isolated. A) CFSE labeled effec-
tor and unlabeled P815 target cells were incubated at the indicated ratios for 4 hours. Subsequently the percentage of 
unlabeled cells, staining positive for 7-AAD, was determined by FACS and B) specific lysis was calculated (mean ± SD, n = 4, 
significant difference of * CD11c+ (open squares) versus CD11c- cells (open circles) or # anti-CD11c-mAb pretreated CD11c+ 
(filled triangles) versus CD11c- cells, p < 0.05) C) Freshly isolated lung cells were stained with anti-CD8, anti-CD11c and RSV 
M2-pentamer. Dot plots show expression of CD11c without or with RSV M2-pentamer staining on cells gated for CD8 
expression. D) Isolated CD8+11c+ or CD8+11c- cells (2.5 × 105) were adoptively transferred to the lungs 1 hour after RSV 
infection of recipients. Controls only received PBS intra-tracheally after infection. Lung RSV titers were determined by plaque 
assay on dpi 4. Depicted are mean ± SD from 2 independent experiments (n = 6, * significant difference, p < 0.05, CD11c+ 
(black bar) versus PBS group (open bar) and CD11c- cells (hatched bar).
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CD8+ T cells (purity > 99%) did not have any effect, but
transfer with tenfold higher numbers of CD11c- CD8+ T
cells also reduced RSV titers in the lung significantly (data
not shown).
Preferential recruitment of CD11c+ CD8+T cells to the lung
As CD11c expression is associated with activation of virus-
specific T cells but does not seem to have a specific, non-
redundant function in cytotoxic activity, we asked if
CD11c may be involved in migration of these cells to the
lung. CD8+ cells containing 49.9 ± 1.2 % CD11c+ cells
were isolated from lungs of mice 8 days after RSV infec-
tion, labeled with CFSE and injected intravenously into
naïve mice, to assess their migratory behavior. Lungs and
spleens of recipient mice were harvested 3 hours after cell
transfer and the percentage of CD11c+ cells in the popula-
tion of CFSE+ CD8+ cells, was analyzed by FACS (Figure
4a). In lungs of naïve mice 52.9 ± 13.6% of transferred
CD8+ cells were CD11c+, while only 12.2 ± 3.6% stained
positive for CD11c in the spleen. Total numbers of
CD11c+ CD8+ T cells migrating to the lung (10.4 ± 8.4 ×
103, n = 5, p < 0.05) were also significantly higher than
those reaching the spleen (6.3 ± 4.5 × 103) in naïve mice.
While the percentages of CD11c+ cells of CFSE labeled
CD8+ T cells in the organs did not change significantly
when cells were transferred into RSV infected mice (Figure
4b), absolute numbers of CD11c+ CD8+ T cells migrating
to the lung increased significantly to 20.0 ± 7.2 × 103, (n
= 5, p < 0.05). In contrast, migration to the spleen did not
change significantly if recipients were RSV infected (2.9 ±
2.8 × 103). Further, no significant changes were observed
when cells were harvested 24 instead of 3 hours after cell
transfer (data not shown). Pre-incubation of CD8+ cells
with two different anti-CD11c-mAbs (clone HL3 or clone
N418) did not affect recruitment into the lung.
Discussion
Expression of β2 integrins on T cells following viral infec-
tions has been described in lymphatic organs [7,8,11] but
knowledge about integrin expression on T cells following
respiratory infections is scarce. Previously, we have
described a population of CD8+ T cells in the lung express-
ing the β2 integrin CD11c following RSV infection [14]. To
characterize these cells in more detail, we have performed
a time course analysis of CD3+ cells displaying CD11c,
thus excluding cells of myeloid origin. In mediastinal
lymph nodes, where CD11c+ cell numbers increase during
inflammation [17,18], CD8α expressing dendritic cells
[19,20] could be mistaken for CD11c+ CD8+ T cells if ana-
lyzed based on CD11c and CD8α only. Following RSV
infection, CD11c expression on lung CD8+ T cells
increased with up to 50% of CD8 T cells positive for
CD11c on dpi8, while, in contrast to LCMV infection, per-
centages of CD11c+ CTL in spleen and blood were low.
CD11c up-regulation on mucosal T cells has previously
only been described in the intestine where a subpopula-
tion of intraepithelial T cells expresses CD11c constitu-
tively [10]. In the lung, expression of CD11c on T cells was
restricted to CD8+ T cells and was paralleled by increases
in CD11b. In contrast to CD11b and CD11c, expression
of F4/80 was hardly detectable on pulmonary T cells fol-
lowing RSV infection. Expression of F4/80 may be
dependent on both mouse strain and organ analyzed: F4/
80+ T cells seem to be more prevalent in C57Bl/6 than in
BALB/c mice [11] and were detectable in significant
amounts only on splenic CD8+ T cells, as shown here and
by Lin and colleagues [11]. In contrast to viral infections,
allergic airway inflammation elicited by sensitization to
OVA, resulted only in a small population of CD11c+ CD8+
T cells in the lung, demonstrating that up-regulation of
CD11c is not a consequence of T cell activation and
migration per se or of an inflammatory environment, but
that it is dependent on the underlying pathology. Interest-
ingly, reactivation of antigen-specific CD8+ memory T
cells by OVA results in CD11c up-regulation when cells
are primed with an OVA-expressing virus [21]. This sug-
gests that MHC class I-restricted antigen presentation as
well as co-stimulatory factors induced by viral infection,
e.g. IFNα, favor expression of CD11c on CD8+ T cells. Sev-
eral studies have demonstrated up-regulation of CD11a
[22], expression of CD11b [7,8,23] or CD11c [11] on T
cells following viral infections. Here, we demonstrate that
following RSV infection a population of CTL co-expresses
CD11ahi, CD11b and CD11c. Furthermore CD11c mRNA
was detectable in resting as well as activated CD8+ T cells.
Contamination by CD11c+ non-T cells cannot be
excluded completely but is very unlikely to account for
CD11c mRNA detection in CD8 T cells since no major dif-
ference in CD11c mRNA quantity was detected between
CD8+ and CD11c+ cell populations. CD11c mRNA seems
to be expressed constitutively in CD8+ T cells while expres-
sion of CD11c protein on the cell surface requires activa-
tion. This notion is supported further by the finding that
activation markers were up regulated on CD11c+ T cells
both in the lung and in the draining MLN. Interestingly,
CD11b mRNA is also expressed in resting as well as acti-
vated human T cells but CD11b becomes detectable on
the cell surface only following stimulation of T cells [24].
Taken together these observations make it tempting to
speculate that there may be a common mechanism of
post-transcriptional regulation of β2 integrin expression
following T cell activation.
Assessing functional properties of CD11c+ CD8+ T cells,
we found that these were more efficient than CD11c-
CD8+ T cells in IFNγ production, target cell lysis in vitro
and induction of viral clearance in vivo. This is likely due
to the fact that the CD11c+ CTL population contains the
majority of activated T cells specific for the RSV M282–90-
peptide, the immuno-dominant CTL epitope of RSV in
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BALB/c mice. Thus, we show an association of adhesion
molecule expression and high cytotoxic activity of
pulmonary CD8+ T cells during a respiratory viral infec-
tion, parallel to findings in lymphoid organs in LCMV
infection [8,11]. A subset of CD11c- CD8+ T cells
expressed high levels of the activation marker CD69 and
low levels of CD62L. Cytotoxic effects induced by CD11c-
CD8+ cells could be due to this subpopulation of activated
CD11c- CTL. We cannot exclude this, since we did not
assess cytotoxic effects of isolated subpopulations of
Irrespective of infection, CD11c+ T cells are recruited to the lung more effectively that to the spleenFigur  4
Irrespective of infection, CD11c+ T cells are recruited to the lung more effectively that to the spleen. Lungs 
were harvested on day 8 after RSV infection; CD8+ cells were isolated by magnetic cell sorting and labeled with CFSE. Subse-
quently cells were adoptively transferred by intravenous injection into naive or RSV infected mice. 3 hours after transfer lungs 
and spleens of recipient mice were harvested and expression of CD11c on transferred cells was analyzed by FACS. A) Dot 
plots show gating of transferred CFSE+CD8+ cells and staining of gated cells with isotype control or anti-CD11c antibody. B) 
The bars indicate percentage of transferred CSFE+ CD8+ cells staining positive for CD11c in lungs and spleens after pre-incuba-
tion of transferred cells with isotype control (open bars) or anti-CD11c-mAb (hatched bars) (mean ± SD, n = 4, * significant 
difference, p < 0.05, lung naïve and lung RSV versus spleen naïve and spleen RSV).
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CD11c- CD8+ T cells. We believe though, that contamina-
tion with CD11c+ CTL is a more likely explanation for
cytotoxic activity observed when CD11c- cells were used as
effectors. In contrast to a study implicating CD11c on
human T cell lines in target cell binding [25] we could not
detect an inhibitory effect of anti-CD11c-mAb on the
cytotoxic activity of T cells. In addition to target cell bind-
ing, β2 integrins are involved in migration of leukocytes
and a role for CD11b in recruitment of T cells into
inflamed areas has been shown by antibody blocking
experiments [9]. In our model, the percentage of CD11c+
cells within the CD8+ T cell population differed between
the organs assessed, being lowest in MLN and spleen,
higher in the blood, where a short-lived increase of these
cells was noted during the acute phase of infection, and
highest in the lung. This indicates that CD11c marks effec-
tor T cells, which are recruited to the site of infection. An
analogous pattern of tissue distribution has been
described for VLA-4hi T cells following intra-cerebral
LCMV infection [8]. Interestingly, following adoptive
transfer we observed efficient recruitment of CD11c+
CD8+ T cells to the lung in naïve mice, while only a small
percentage of these cells were recruited to the spleen. This
preferential recruitment of CD11c+ CD8+ T cells to the
lung was even more pronounced in RSV infected recipi-
ents. Pre-treatment of transferred cells with anti-CD11c-
mAb did not reveal a unique function of CD11c for hom-
ing of activated CTL to the lung. These observations sug-
gest that CD11c is a marker for activated CTL, which are
recruited preferentially to the lung, while the CD11c mol-
ecule itself may not be directly involved in the process of
T cell recruitment to the lung. Functional redundancy of
β2 integrins in target cell binding or migration into effec-
tor sites is a possible explanation of our results. CD11a
has been shown to be important for target cell binding
[26], recruitment of activated lymphocytes into the lung
[5,27] and generation of an effective cytotoxic T cell
response during primary RSV infection [28].
Conclusion
We demonstrate that the β2 integrin, CD11c, identifies a
subset of activated, virus-specific, cytotoxic CD8+ T cells.
These cells are preferentially recruited to the lung in RSV
infection and exhibit potent antiviral effects in vivo.
CD11c is expressed by CD8+ T cells, but this molecule may
not be directly involved in effector functions. Thus, fol-
lowing respiratory viral infections CD11c is a useful
marker for detection and isolation of activated, cytotoxic,
pulmonary T cells, provided distinction from myeloid
cells is taken into account.
Abbreviations
7-AAD 7-Aminoactinomycin D
APC antigen presenting cells
CFSE 5-(and-6)-carboxyfluorescein diacetate, succinimi-
dyl ester
CTL cytotoxic T lymphocytes
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